KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $306.0 million.

  • Bausch Health Companies' Depreciation & Amortization (CF) fell 496.89% to $306.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 496.51%. This contributed to the annual value of $1.3 billion for FY2024, which is 23.73% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Depreciation & Amortization (CF) is $306.0 million, which was down 496.89% from $307.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Depreciation & Amortization (CF) registered a high of $404.0 million during Q2 2021, and its lowest value of $301.0 million during Q3 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $336.6 million, with a median of $322.0 million in 2024.
  • In the last 5 years, Bausch Health Companies' Depreciation & Amortization (CF) crashed by 1621.62% in 2021 and then surged by 697.67% in 2024.
  • Over the past 5 years, Bausch Health Companies' Depreciation & Amortization (CF) (Quarter) stood at $363.0 million in 2021, then fell by 0.83% to $360.0 million in 2022, then decreased by 8.61% to $329.0 million in 2023, then decreased by 6.69% to $307.0 million in 2024, then fell by 0.33% to $306.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $306.0 million for Q3 2025, versus $307.0 million for Q2 2025 and $305.0 million for Q1 2025.